vs
JBG SMITH Properties（JBGS）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是JBG SMITH Properties的1.6倍（$197.9M vs $127.6M），REPLIGEN CORP净利率更高（6.7% vs -35.7%，领先42.4%），REPLIGEN CORP同比增速更快（13.6% vs -2.5%），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs -6.3%）
JBG SMITH Properties是一家总部位于马里兰州贝塞斯达的上市房地产投资信托公司，专注于持有并运营房地产资产，是美国商业地产领域的专业运营机构，面向市场提供多元化的不动产投资与管理服务。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
JBGS vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.6倍
$127.6M
营收增速更快
RGEN
高出16.1%
-2.5%
净利率更高
RGEN
高出42.4%
-35.7%
两年增速更快
RGEN
近两年复合增速
-6.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $127.6M | $197.9M |
| 净利润 | $-45.5M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | -47.5% | 9.0% |
| 净利率 | -35.7% | 6.7% |
| 营收同比 | -2.5% | 13.6% |
| 净利润同比 | 24.0% | 143.9% |
| 每股收益（稀释后） | $-0.76 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收JBGSRGEN
| Q4 25 | $127.6M | $197.9M | ||
| Q3 25 | $123.9M | $188.8M | ||
| Q2 25 | $126.5M | $182.4M | ||
| Q1 25 | $120.7M | $169.2M | ||
| Q4 24 | $130.8M | $174.1M | ||
| Q3 24 | $136.0M | $154.9M | ||
| Q2 24 | $135.3M | $154.1M | ||
| Q1 24 | $145.2M | $151.3M |
净利润JBGSRGEN
| Q4 25 | $-45.5M | $13.3M | ||
| Q3 25 | $-28.6M | $14.9M | ||
| Q2 25 | $-19.2M | $14.9M | ||
| Q1 25 | $-45.7M | $5.8M | ||
| Q4 24 | $-59.9M | $-30.3M | ||
| Q3 24 | $-27.0M | $-654.0K | ||
| Q2 24 | $-24.4M | $3.3M | ||
| Q1 24 | $-32.3M | $2.1M |
毛利率JBGSRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率JBGSRGEN
| Q4 25 | -47.5% | 9.0% | ||
| Q3 25 | -27.5% | 8.9% | ||
| Q2 25 | -18.4% | 7.6% | ||
| Q1 25 | -44.7% | 3.9% | ||
| Q4 24 | -53.6% | -17.7% | ||
| Q3 24 | -22.4% | -5.1% | ||
| Q2 24 | -24.3% | 1.0% | ||
| Q1 24 | -30.1% | 1.3% |
净利率JBGSRGEN
| Q4 25 | -35.7% | 6.7% | ||
| Q3 25 | -23.1% | 7.9% | ||
| Q2 25 | -15.2% | 8.2% | ||
| Q1 25 | -37.9% | 3.4% | ||
| Q4 24 | -45.8% | -17.4% | ||
| Q3 24 | -19.8% | -0.4% | ||
| Q2 24 | -18.0% | 2.2% | ||
| Q1 24 | -22.2% | 1.4% |
每股收益（稀释后）JBGSRGEN
| Q4 25 | $-0.76 | $0.24 | ||
| Q3 25 | $-0.48 | $0.26 | ||
| Q2 25 | $-0.29 | $0.26 | ||
| Q1 25 | $-0.56 | $0.10 | ||
| Q4 24 | $-0.70 | $-0.55 | ||
| Q3 24 | $-0.32 | $-0.01 | ||
| Q2 24 | $-0.27 | $0.06 | ||
| Q1 24 | $-0.36 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $75.3M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $1.2B | $2.1B |
| 总资产 | $4.4B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资JBGSRGEN
| Q4 25 | $75.3M | $767.6M | ||
| Q3 25 | $64.4M | $748.7M | ||
| Q2 25 | $61.4M | $708.9M | ||
| Q1 25 | $81.3M | $697.2M | ||
| Q4 24 | $145.8M | $757.4M | ||
| Q3 24 | $137.0M | $784.0M | ||
| Q2 24 | $163.5M | $809.1M | ||
| Q1 24 | $220.5M | $780.6M |
总债务JBGSRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益JBGSRGEN
| Q4 25 | $1.2B | $2.1B | ||
| Q3 25 | $1.2B | $2.1B | ||
| Q2 25 | $1.3B | $2.1B | ||
| Q1 25 | $1.6B | $2.0B | ||
| Q4 24 | $1.8B | $2.0B | ||
| Q3 24 | $1.9B | $2.0B | ||
| Q2 24 | $2.0B | $2.0B | ||
| Q1 24 | $2.1B | $2.0B |
总资产JBGSRGEN
| Q4 25 | $4.4B | $2.9B | ||
| Q3 25 | $4.4B | $2.9B | ||
| Q2 25 | $4.5B | $2.9B | ||
| Q1 25 | $4.7B | $2.9B | ||
| Q4 24 | $5.0B | $2.8B | ||
| Q3 24 | $5.2B | $2.8B | ||
| Q2 24 | $5.3B | $2.9B | ||
| Q1 24 | $5.4B | $2.8B |
负债/权益比JBGSRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $73.3M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | — | $17.6M |
| 自由现金流率自由现金流/营收 | — | 8.9% |
| 资本支出强度资本支出/营收 | — | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | — | $93.9M |
8季度趋势，按日历期对齐
经营现金流JBGSRGEN
| Q4 25 | $73.3M | $25.7M | ||
| Q3 25 | $8.9M | $48.1M | ||
| Q2 25 | $18.8M | $28.6M | ||
| Q1 25 | $12.9M | $15.0M | ||
| Q4 24 | $129.4M | $39.2M | ||
| Q3 24 | $26.4M | $49.3M | ||
| Q2 24 | $23.8M | $42.2M | ||
| Q1 24 | $37.0M | $44.7M |
自由现金流JBGSRGEN
| Q4 25 | — | $17.6M | ||
| Q3 25 | — | $43.4M | ||
| Q2 25 | — | $21.5M | ||
| Q1 25 | — | $11.4M | ||
| Q4 24 | — | $33.6M | ||
| Q3 24 | — | $42.3M | ||
| Q2 24 | — | $37.4M | ||
| Q1 24 | — | $36.4M |
自由现金流率JBGSRGEN
| Q4 25 | — | 8.9% | ||
| Q3 25 | — | 23.0% | ||
| Q2 25 | — | 11.8% | ||
| Q1 25 | — | 6.8% | ||
| Q4 24 | — | 19.3% | ||
| Q3 24 | — | 27.3% | ||
| Q2 24 | — | 24.3% | ||
| Q1 24 | — | 24.0% |
资本支出强度JBGSRGEN
| Q4 25 | — | 4.1% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 3.9% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 5.5% |
现金转化率JBGSRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
